# Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty

> **NCT04075526** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 2129 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Povidone iodine
- **DRUG:** Vancomycin powder
- **OTHER:** Conventional

## Key facts

- **NCT ID:** NCT04075526
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2025-12-13
- **Target enrollment:** 2129 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04075526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04075526, "Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04075526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*